Terms: = Prostate cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Prognosis
96 results:
1. Preoperative PI-RADS v2.1 Scoring System Improves Risk Classification in Patients Undergoing Radical prostatectomy.
Fukui Y; Yamada Y; Sakamoto S; Horikoshi T; Zhao X; Sato K; Nanba S; Kubota Y; Kanesaka M; Fujimoto A; Shibata H; Goto Y; Sazuka T; Imamura Y; Uno T; Ichikawa T
Anticancer Res; 2023 Dec; 43(12):5705-5712. PubMed ID: 38030183
[TBL] [Abstract] [Full Text] [Related]
2. Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
Zhang H; Yang Y; Xing W; Li Y; Zhang S
BMC Cancer; 2023 Nov; 23(1):1124. PubMed ID: 37978469
[TBL] [Abstract] [Full Text] [Related]
3. Mortality Risk for Docetaxel-Treated, High-Grade prostate cancer With Low PSA Levels: A Meta-Analysis.
Mahal BA; Kwak L; Xie W; Eastham JA; James ND; Sandler HM; Feng FY; Brihoum M; Fizazi K; Sweeney C; Ravi P; D'Amico AV
JAMA Netw Open; 2023 Nov; 6(11):e2340787. PubMed ID: 37910103
[TBL] [Abstract] [Full Text] [Related]
4. Tumor localization by prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy.
Fujimoto A; Sakamoto S; Horikoshi T; Zhao X; Yamada Y; Rii J; Takeuchi N; Imamura Y; Sazuka T; Matsusaka K; Ikeda JI; Ichikawa T
Sci Rep; 2023 Jun; 13(1):10079. PubMed ID: 37344491
[TBL] [Abstract] [Full Text] [Related]
5. Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine prostate cancer Coexisting with Androgen Receptor Pathway prostate cancer.
Watanabe R; Miura N; Kurata M; Kitazawa R; Kikugawa T; Saika T
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240308
[TBL] [Abstract] [Full Text] [Related]
6. Predictors of Recurrence After Metastasis-directed Therapy in Oligorecurrent prostate cancer Following Radical prostatectomy.
Milenkovic U; Kuijk J; Roussel E; Devos G; Van den Broeck T; Van Eecke H; Vanderstichele A; Duvillier T; Verhamme L; Van Haute W; Goeman L; Berghen C; Joniau S; De Meerleer G
Eur Urol Oncol; 2023 Dec; 6(6):582-589. PubMed ID: 36878753
[TBL] [Abstract] [Full Text] [Related]
7. Incidence, mortality and survival of prostate cancer in two municipalities with a high human development index in Mato Grosso, Brazil.
Evangelista FM; Melanda FN; Modesto VC; Soares MR; Neves MABD; Souza BDSN; Sousa NFDSE; Galvão ND; Andrade ACS
Rev Bras Epidemiol; 2022; 25(Supl 1):e220016. PubMed ID: 35766773
[TBL] [Abstract] [Full Text] [Related]
8. Conditional Survival of Patients With Extracranial Oligometastatic Treated With Stereotactic Body Radiation Therapy: An International Consortium Study.
Chen H; Badellino S; Biswas T; Dagan R; Erler D; Foote M; Poon I; Redmond KJ; Ricardi U; Sahgal A; Louie AV
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):902-909. PubMed ID: 35753554
[TBL] [Abstract] [Full Text] [Related]
9. MRI-Detectability of Clinically Significant prostate cancer Relates to Oncologic Outcomes After prostatectomy.
Wibmer AG; Lefkowitz RA; Lakhman Y; Chaim J; Nikolovski I; Sala E; Fine SW; Donahue TF; Kattan MW; Hricak H; Vargas HA
Clin Genitourin Cancer; 2022 Aug; 20(4):319-325. PubMed ID: 35618599
[TBL] [Abstract] [Full Text] [Related]
10. [Skull base metastases with cranial nerve deficits : Clinical profile of a severe disease].
Hoppe J; Kalckreuth T; Metelmann M; Rumpf JJ; Klagges S; Dietzsch S; Scherlach C; Kuhnt T; Kortmann RD; Seidel C
Nervenarzt; 2022 Aug; 93(8):812-818. PubMed ID: 35024880
[TBL] [Abstract] [Full Text] [Related]
11. Glycemic control was associated with nonprostate cancer and overall mortalities in diabetic patients with prostate cancer.
Lin CC; Wu MF; Chang YL; Sheu WH; Liou WS
J Chin Med Assoc; 2022 Mar; 85(3):331-340. PubMed ID: 34561410
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological characteristics and survival outcomes in neuroendocrine prostate cancer: A population-based study.
Zhu J; Liang X; Wu D; Chen S; Yang B; Mao W; Shen D
Medicine (Baltimore); 2021 Apr; 100(15):e25237. PubMed ID: 33847621
[TBL] [Abstract] [Full Text] [Related]
13. A Novel Nomogram for Survival Prediction of Patients with Spinal Metastasis From prostate cancer.
Liu Y; Li L; Jiang D; Yang M; Gao X; Lv K; Xu W; Wei H; Wan W; Xiao J
Spine (Phila Pa 1976); 2021 Mar; 46(6):E364-E373. PubMed ID: 33620180
[TBL] [Abstract] [Full Text] [Related]
14. Oncologic Outcomes after Localized prostate cancer Treatment: Associations with Pretreatment prostate Magnetic Resonance Imaging Findings.
Wibmer AG; Chaim J; Lakhman Y; Lefkowitz RA; Nincevic J; Nikolovski I; Sala E; Gonen M; Carlsson SV; Fine SW; Zelefsky MJ; Scardino P; Hricak H; Vargas HA
J Urol; 2021 Apr; 205(4):1055-1062. PubMed ID: 33207133
[TBL] [Abstract] [Full Text] [Related]
15. Multiple primary malignancies involving lung cancer: a single-center experience.
Ventura L; Carbognani P; Gnetti L; Rossi M; Tiseo M; Silini EM; Sverzellati N; Silva M; Succi M; Braggio C; Cattadori S; Bocchialini G; Balestra V; Rusca M; Ampollini L
Tumori; 2021 Jun; 107(3):196-203. PubMed ID: 32578517
[TBL] [Abstract] [Full Text] [Related]
16. Does minimum follow-up time post-diagnosis matter? An assessment of changing loss of life expectancy for people with cancer in Western Australia from 1982 to 2016.
Wright CM; Moorin RE
Cancer Epidemiol; 2020 Jun; 66():101705. PubMed ID: 32224327
[TBL] [Abstract] [Full Text] [Related]
17. Suicide risk among prostate cancer patients before and after the implementation of prostate-specific antigen-based prostate screening in Lithuania in 2006.
Patasius A; Kaceniene A; Ulys A; Stukas R; Smailyte G
Eur J Cancer Prev; 2021 Jan; 30(1):103-107. PubMed ID: 32039931
[TBL] [Abstract] [Full Text] [Related]
18. Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
Carrie C; Magné N; Burban-Provost P; Sargos P; Latorzeff I; Lagrange JL; Supiot S; Belkacemi Y; Peiffert D; Allouache N; Dubray BM; Servagi-Vernat S; Suchaud JP; Crehange G; Guerif S; Brihoum M; Barbier N; Graff-Cailleaud P; Ruffion A; Dussart S; Ferlay C; Chabaud S
Lancet Oncol; 2019 Dec; 20(12):1740-1749. PubMed ID: 31629656
[TBL] [Abstract] [Full Text] [Related]
19. Significance of examined lymph-node count in accurate staging and long-term survival in patients undergoing radical prostatectomy: a population-based study.
Chen C; Shen J; Xing Z; Jiang C; Hu L; Cui L; Xue D; He X; Xu R
Int Urol Nephrol; 2020 Feb; 52(2):271-278. PubMed ID: 31571158
[TBL] [Abstract] [Full Text] [Related]
20. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
[TBL] [Abstract] [Full Text] [Related]
[Next]
